Fri, Aug 29, 2014, 9:05 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

IMMUNICON CORP Message Board

  • fearbuying fearbuying Mar 22, 2007 11:05 PM Flag

    Patient Testimonials in Dallas

    It's amazing what you can find on the web these days. Interestingly, this article mentions someone with colorectal cancer, and also mentions studies for lung and melanoma. From WFAA-TV in Dallas:



    Mindy Bradley is ready to beat breast cancer for a second time.

    It wasn't a standard mammogram that found her disease, but a new test at the Mary Crowley Medical Research Center in Dallas.

    "I believe in my heart of hearts, that had I waited and eventually continued with the traditional treatment or conventional treatment however you want to word it, I would not be alive," Bradley said.

    CellSearch can scan a vial of blood and detect a single cancer cell floating in it.

    To put that in perspective, a tiny tumor the size of a piece of rice has about a million cells; a pea-sized tumor has nearly a billion cells.

    "If we can pick it up early, maybe where it's still surgically resectable or we can use radiation, then there's a much better chance of protecting long-term survival and durable effect from cancer treatment," said oncologist Dr. John Nemunaitis.

    Before now, blood tests only detected blood cancer.

    CellSearch was recently approved by the Food and Drug Administration to find breast cancer in the blood. It is being studied for prostate, lung, and melanoma detection as well.

    CellSearch has detected minute jumps in the number of colon cancer cells in Bill Latham's body.

    "I live from Friday to Friday," he said.

    "Instead of just watching and waiting and just sitting on things, maybe it's wiser to go with a targeted therapy, because the machine showed maybe his cancer was starting to get active again," Dr. Nemunaitis said.

    He hopes CellSearch will continue to pinpoint when patients like Bill Latham and Mindy Bradley need treatment, so they can continue to live from Friday to Friday.

    "I believe that this particular test, I hope, has saved my life," Bradley said.

    CellSearch right now is being used to monitor cancer is people already diagnosed with the disease, but it's hoped it could one day be a screening test.

    The exam costs about $500, and it can be covered by insurance.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IMMCQ
0.0060.000(0.00%)Jul 24 3:27 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.